A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects

Clinical trial NCT01109680 · COMPLETED

Trial details

NCT number: NCT01109680
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metabolism of Neramexane

Start date: 2010-04-01
Primary completion: 2010-06-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.